CA1289885C - Tissue growth regulation - Google Patents

Tissue growth regulation

Info

Publication number
CA1289885C
CA1289885C CA000520028A CA520028A CA1289885C CA 1289885 C CA1289885 C CA 1289885C CA 000520028 A CA000520028 A CA 000520028A CA 520028 A CA520028 A CA 520028A CA 1289885 C CA1289885 C CA 1289885C
Authority
CA
Canada
Prior art keywords
solution
temperature
biotin
acetyl
tissue growth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA000520028A
Other languages
English (en)
French (fr)
Inventor
Neil G.C. Hendry
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of CA1289885C publication Critical patent/CA1289885C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA000520028A 1985-10-08 1986-10-07 Tissue growth regulation Expired - Lifetime CA1289885C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB858524807A GB8524807D0 (en) 1985-10-08 1985-10-08 Tissue growth regulation
GB8524807 1985-10-08

Publications (1)

Publication Number Publication Date
CA1289885C true CA1289885C (en) 1991-10-01

Family

ID=10586368

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000520028A Expired - Lifetime CA1289885C (en) 1985-10-08 1986-10-07 Tissue growth regulation

Country Status (10)

Country Link
EP (1) EP0239607A1 (cs)
JP (1) JPS63501077A (cs)
AU (1) AU606038B2 (cs)
CA (1) CA1289885C (cs)
CS (1) CS265224B2 (cs)
DD (1) DD272034A5 (cs)
GB (1) GB8524807D0 (cs)
IN (1) IN168295B (cs)
WO (1) WO1987002244A1 (cs)
ZA (1) ZA867664B (cs)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5273900A (en) * 1987-04-28 1993-12-28 The Regents Of The University Of California Method and apparatus for preparing composite skin replacement
CA1318592C (en) * 1988-11-18 1993-06-01 University Of British Columbia N-acetyl glucosamine as a cytoprotective agent
US5192750A (en) * 1992-01-28 1993-03-09 The University Of British Columbia Method and composition for treatment of food allergy
US5229374A (en) * 1992-01-28 1993-07-20 Burton Albert F Method for treatment of lower gastrointestinal tract disorders
US5217962A (en) * 1992-01-28 1993-06-08 Burton Albert F Method and composition for treating psoriasis
US6046179A (en) * 1998-04-17 2000-04-04 Murch; Simon Composition for and treatment of inflammatory bowel disease by colon administration of N-acetylglucosamine
US6159485A (en) 1999-01-08 2000-12-12 Yugenic Limited Partnership N-acetyl aldosamines, n-acetylamino acids and related n-acetyl compounds and their topical use
CN1173706C (zh) 2001-02-28 2004-11-03 中国人民解放军第三军医大学 N-乙酰-d-氨基葡萄糖在制备治疗宫颈糜烂药物中的应用
CN1199645C (zh) 2002-08-13 2005-05-04 中国人民解放军第三军医大学 N－乙酰－d－氨基葡萄糖在制备治疗泌尿生殖道感染药物中的应用
WO2005025581A1 (fr) * 2003-09-17 2005-03-24 Third Military Medical University, Chinese People's Liberation Army, P.R. Of China Utilisation de la n-acetyl-d-aminoglycosamine pour la preparation de medicaments de traitement du cancer et des metastases
CA2551613A1 (en) * 2004-05-21 2005-12-01 Tottori University A composition comprising n-acetyl-d-glucosamine for treatment of wound
ITBS20070178A1 (it) * 2007-11-15 2009-05-16 Paoli Ambrosi Gianfranco De Composizione per uso farmaceutico e/o cosmetico e/o in forma di dispositivo medico per favorire processi di cicatrizzazione, per il trattamento di cicatrici ipertrofiche e per migliorare le proprieta' biomeccaniche della cute

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3232836A (en) * 1959-08-24 1966-02-01 Pfizer & Co C Facilitating healing of body surface wounds by intravenous administration of n-acetyl glucosamine, glucosamine, or pharmaceutically acceptable acid salts of glucosamine

Also Published As

Publication number Publication date
WO1987002244A1 (en) 1987-04-23
DD272034A5 (de) 1989-09-27
AU606038B2 (en) 1991-01-31
IN168295B (cs) 1991-03-09
EP0239607A1 (en) 1987-10-07
GB8524807D0 (en) 1985-11-13
CS265224B2 (en) 1989-10-13
JPS63501077A (ja) 1988-04-21
CS729286A2 (en) 1989-01-12
AU6409486A (en) 1987-05-05
ZA867664B (en) 1987-05-27

Similar Documents

Publication Publication Date Title
US3887703A (en) Mucopolysaccharides, their preparation and use in cosmetic and pharmaceutical compositions
CA1261258A (en) Angiogenic factor and method for producing angiogenesis
CA1289885C (en) Tissue growth regulation
DK174400B1 (da) Acylderivater af deoxyribonucleosider og farmaceutiske præparater indeholdende disse
EP0147375A1 (en) Water-soluble aminated Beta-1,3-bound D-glucan and composition containing same
EP0296620A2 (en) Use of N-acetylneuraminic-acid salts for the preparation of a medicament for decongesting nasal mucous membranes
KR19980702251A (ko) 간질성(間質性) 방광염 치료를 위한 히알루론산의 용도
DE3267039D1 (en) Stable s-adenosylmethionine salts, the process for their preparation and therapeutic compositions which contain them as active principle
US4308257A (en) Accelerating cellular repair composition for the human body and method of administering same
WO1992002231A1 (en) Anti-human immunodeficiency virus agent
Whitby Enzymic formation of a new riboflavin derivative
JPH10182703A (ja) 低分子量のフカン類とその医薬組成物
EP0410002A1 (en) Anti-hiv drug
JPH0427964B2 (cs)
JPH0245495A (ja) ビスマス（リン酸／硫酸）サッカリド
KR100240544B1 (ko) 혈관 내막 비후 억제제
CA1286227C (en) Externally applicable, antiviral pharmaceutical composition accumulating in the skin and process for the preparation of same
US4436732A (en) Medicated compound for treating diseases infected by virus of the herpes group
Sneddon Congenital porphyria
JP3769045B2 (ja) 抗炎症剤
OTSUKA et al. Inhibitory Effect of D-Penicillamine on Degradation of Hexosaminecontaining Substances in the Involution of Carrageenin Granuloma induced by Calcium Chelate Ethylenediaminetetraacetate
Oohira et al. Limb anomalies produced by 2, 2′‐dipyridyl in rats
Bruch Recent progress in insulin physiology
Carr et al. Effect of alginate on the absorption and excretion of 203Pb in rats fed milk and normal diets
JP3009164B2 (ja) 燐糖基剤の抗炎症剤及び／または免疫抑制剤

Legal Events

Date Code Title Description
MKLA Lapsed